Apigenin exhibits anti-tumor effects by decelerating growth and inducing apoptosis through activation of pentose phosphate pathway-mediated NADPH generation in HepG2 human hepatoma cells, induction of apoptosis via the PI3K/AKT and ERK1/2 MAPK pathways, decreasing the viability, adhesion, and migration of cancer cells and modulating angiogenesis and metastasis (68). The gene discussed is AKT1; the disease is hepatocellular carcinoma.